NPR logo

SSRI Studies Expose Conflicting Roles for FDA

  • Download
  • <iframe src="https://www.npr.org/player/embed/3935821/3935822" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
SSRI Studies Expose Conflicting Roles for FDA

Children's Health

SSRI Studies Expose Conflicting Roles for FDA

SSRI Studies Expose Conflicting Roles for FDA

  • Download
  • <iframe src="https://www.npr.org/player/embed/3935821/3935822" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

NPR's Joanne Silberner looks at whether the Food and Drug Administration (FDA) can both ensure public safety and industry confidentiality. The agency has come under tremendous pressure from Congress recently over a class of antidepressant drugs called SSRIs. For months, the FDA had studies questioning the safety and effectiveness of these drugs in children — but didn't make the studies public until pressured by Congress and the media.